논문 목록
20건 · 최신순-
Survey of Canadian Physician Use of Botulinum Toxin A (BoNT-A) for Paratonia: Real World Insights.
Paratonia is a form of hypertonia characterized by an inability to relax muscles in the setting of cognitive impairment. Paratonia results in pain, refusal of care, and caregiver burden. We sent surveys to 67 Canadian physiatrists and neuro…
-
Acute neurophysiologic effects of botulinum toxin type A intramuscular injection on extensor digitorum brevis muscle in healthy adults.
[INTRODUCTION] Anecdotal clinical experience shows that patients often indicate that their spasticity improves on the day of treatment with intramuscular botulinum injection. Previous research shows that compound motor action potentials (CM…
- Brief Skin Cooling Prior to Intramuscular Botulinum Toxin Injections.
-
Practice Patterns of Physicians Using Adjunct Therapies with Botulinum Toxin Injection for Spasticity: A Canadian Multicenter Cross-Sectional Survey.
[BACKGROUND] Adjunct therapies are nonpharmacological treatments used with botulinum toxin (BoNT) injection that may improve spasticity outcomes. It has been suggested that physicians consider adjunct therapies as a part of comprehensive sp…
-
Challenges in the management of anticoagulated patients with focal spasticity.
[INTRODUCTION] In patients taking warfarin, the level of anticoagulation status using the International Normalized Ratio (INR) is one consideration before botulinum toxin type-A (BoNTA) injections; however, there is wide diversity in physic…
-
Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study.
In this first, double-blind, randomized, placebo-controlled exploratory trial, we evaluate the efficacy and safety of incobotulinumtoxinA and feasibility of using kinematic tremor assessment to aid in the planning of muscle selection in a m…
-
Interrater Reliability of the Modified Ashworth Scale with Standardized Movement Speeds: A Pilot Study.
The purpose of this study was to estimate the interrater reliability of the Modified Ashworth Scale (MAS) using consistent movement speeds guided by a metronome when measuring wrist flexor and ankle plantar flexor spasticity in patients wit…
-
Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study.
[BACKGROUND] Although therapeutic treatments are intended to help alleviate symptoms associated with disease, safety must be carefully considered and monitored to confirm continued positive benefit/risk balance. The objective of MOBILITY wa…
-
A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity.
[OBJECTIVE] To create a consensus statement on the considerations for treatment of anticoagulated patients with botulinum toxin A (BoNTA) intramuscular injections for limb spasticity. [DESIGN] We used the Delphi method. [SETTING] A multiq…
-
Goals Set by Patients Using the Model before Receiving Botulinum Injections and Their Relation to Spasticity Distribution.
Goal Attainment Scaling (GAS) is used to assess functional gains in response to treatment. Specific characteristics of the functional goals set by individuals receiving botulinum toxin type A (BoNTA) injections for spasticity management are…
-
Effect of Botulinum Toxin on Clonus: A Systematic Review.
[OBJECTIVE] To conduct a systematic review of the literature that examined the effect of botulinum toxin type A on clonus. [DATA SOURCES] A literature search of multiple databases (PubMed, Cochrane, Google Scholar, Embase) was performed to…
-
Patterns of botulinum toxin treatment for spasticity and bleeding complications in patients with thrombotic risk.
The purpose of this study was to assess the prevalence of compartment syndrome or major bleeding episodes and compare compartment syndrome, patient and intervention characteristics in 110 patients with stroke (treated with Warfarin, new ora…
-
Adverse Clinical Effects of Botulinum Toxin Intramuscular Injections for Spasticity.
[OBJECTIVE] The adverse events (AEs) with botulinum toxin type-A (BoNTA), used for indications other than spasticity, are widely reported in the literature. However, the site, dose, and frequency of injections are different for spasticity w…
-
Relationship Between Botulinum Toxin, Spasticity, and Pain: a Survey of Patient Perception.
[OBJECTIVE] To assess the prevalence of pain in adults with spasticity and to assess the association between the subjective experience of pain and spasticity. [DESIGN] Cross-sectional study. [SETTING] outpatient spasticity management clin…
-
Survey of Botulinum Toxin Injections in Anticoagulated Patients: Korean Physiatrists' Preference in Controlling Anticoagulation Profile Prior to Intramuscular Injection.
[OBJECTIVE] To evaluate Korean physiatrists' practice of performing intramuscular botulinum toxin injection in anticoagulated patients and to assess their preference in controlling the bleeding risk before injection. [METHODS] As part of a…
-
Correction: Survey of Botulinum Toxin Injections in Anticoagulated Patients: Korean Physiatrists' Preference in Controlling Anticoagulation Profile Prior to Intramuscular Injection.
[This corrects the article on p. 279 in vol. 40, PMID: 27152278.].…
-
Physician Preferences for Botulinum Toxin Injections in Anticoagulated Patients with Spasticity.
To understand physician preferences and bleeding complication rates of intramuscular botulinum neurotoxin type A injections for spasticity management in anticoagulated patients, questionnaires were mailed to 138 physicians across Canada. Th…
-
Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment.
[BACKGROUND] OnabotulinumtoxinA is an efficacious treatment option for patients with various conditions. Although studies have reported on the efficacy of onabotulinumtoxinA, quality of life (QoL) data are limited. This study evaluated QoL …
- Spasticity Health Literacy Among Canadian Family Physicians.
- Biceps Brachii Botulinum Toxin Injections: To Be or Not to Be.